COR
US EQUITY
Health Care
Health Care Distributors
CIK: 1140859
Cencora (COR) Quant Factor Diagnostic & Fair Value Model
Cencora (Ticker: COR) is listed in the Health Care sector (Health Care Distributors). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$331.00
-2.21%
Latest Close (2026-10-23)
Market Cap: $4.21B
P/E Ratio: 21.0
Momentum Strength
3M / 12M
+6.38%
1M: +6.82%
12M: +0.06%
Quality (ROE)
Point-in-Time
+12.41%
Trailing Return on Equity
Technical Trend
RSI 14
68.5
SMA50: $322.04
SMA200: $317.43
Valuation Multiplier
Trailing
21.0
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
COR trades within a typical sector multiple band (21.0x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 8/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1140859 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | $84.75B | $763.52M | $1.69B | $3.94 |
| 10-Q | 2025-09-30 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | $80.66B | $687.40M | $741.70M | $3.52 |
| 10-Q | 2026-03-31 | 2026-05-06 | $78.36B | $1.64B | -$966.53M | $8.40 |
| 10-Q | 2025-03-31 | 2026-05-06 | $75.45B | $717.87M | $632.46M | $3.68 |
| 10-Q | 2025-12-31 | 2026-02-04 | $85.93B | $559.65M | -$2.31B | $2.87 |
| 10-Q | 2024-12-31 | 2026-02-04 | $81.49B | $488.60M | -$2.72B | $2.50 |
| 10-K | 2025-09-30 | 2025-11-25 | $321.33B | $1.55B | $3.88B | $7.96 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Cencora (COR) valuation multiples, momentum factors, and point-in-time filing conventions.
How should COR's current valuation multiple be interpreted? ↓
COR trades at a trailing P/E of 21.0x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are COR's key momentum and technical factor indicators? ↓
As of the latest close, COR shows a 1-month return of +6.82%, 3-month return of +6.38%, and 12-month return of +0.06%, with a 14-day RSI of 68.5. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for COR? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can COR be incorporated into systematic factor models? ↓
COR can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.